Fecal disimpaction in children with enuresis and constipation does not make them dry at night

Malin Borgström1, Amadeus Bergsten2, Maria Tunebjer2

  • 1Department of Women's and Children's Health, Uppsala University, Sweden; Center for Clinical Research Dalarna, Falun, Sweden.

Insights

Fecal disimpaction for constipation in children with nocturnal enuresis did not improve bedwetting. Addressing bowel issues is important, but this method alone does not cure enuresis.

Area of Science:

  • Pediatric Urology
  • Gastroenterology
  • Sleep Medicine

Background:

  • Nocturnal enuresis and constipation frequently coexist in children.
  • Constipation management is crucial for daytime incontinence, but its impact on enuresis is less understood.
  • The efficacy of fecal disimpaction for enuresis in constipated children remains unevaluated.

Purpose of the Study:

  • To assess the effect of fecal disimpaction on nocturnal enuresis in children with co-occurring constipation.
  • To determine if clearing fecal impaction can reduce enuresis frequency.

Main Methods:

  • Noninvasive assessment of bladder and bowel function in children (6-10 years) with new-onset enuresis.
  • Constipation diagnosed via Rome IV criteria or rectal diameter >30mm (ultrasound).
  • Treatment involved mini-enemas and macrogol for at least two weeks; enuresis frequency recorded before and after.

Main Results:

  • 23 out of 66 children (35%) were constipated; no baseline differences in age, sex, or bladder function.
  • Enuresis frequency averaged 9.8 nights/2 weeks before and 9.3 nights/2 weeks after constipation therapy (p=0.43).
  • Fecal disimpaction did not significantly alter enuresis frequency.

Conclusions:

  • Fecal disimpaction alone does not resolve nocturnal enuresis in constipated children.
  • While bowel issues require attention, this treatment does not guarantee nighttime dryness.
  • Evidence-based enuresis therapies may require addressing underlying bowel problems first for optimal efficacy.
Abstract

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
320
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
288
Feces Formation and Defecation01:26

Feces Formation and Defecation

After spending 3 to 10 hours in the large intestine, chyme loses a lot of water and becomes feces, the final product of digestion. Feces consist of undigested dietary fiber such as cellulose, mucus, sloughed-off epithelial cells, and microbes. The descending and sigmoid colon stores feces and uses haustral contractions to dry it out but retains enough water to give it a semi-solid texture.
The mass peristalsis then pushes the feces into the rectum, which stretches the rectal walls to activate...
1.5K
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
435
Assessment of the Rectum and Anus01:25

Assessment of the Rectum and Anus

Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
396
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives01:22

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
303